Cures & Capital
Hello and welcome to Cures & Capital - the podcast on value creation in biotech and pharma.
Together, we are going to dive deep into the world of biotech and pharma to tackle the holy grail - how do we improve return on investment from drug innovation and deliver transformative therapies to patients, efficiently and sustainably.
Hosted by Martin Slezak & Simon Birksø
Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.
Cures & Capital
Aaron Schacht on the pharmaceutical industry's grand challenge and managing R&D at scale
In this episode, we talk to Aaron Schact, the CEO and Board Director at BiomEdit and former R&D leader at Eli Lilly and Elanco.
We discuss how to improve biopharma's R&D productivity and the industry's "grand challenge", why R&D productivity is the mental model for managing R&D at scale, practical advice on how to approach and work with R&D productivity, and much more!
If you want to connect with us - we would love to hear from you:
Linkedin: https://www.linkedin.com/company/cures-capital-podcast
If you prefer to watch the episode as a video, you can also get the podcast from YouTube, just search for "Cures & Capital".
If you want to connect with Aaron or read about BiomEdit:
Linkedin: https://www.linkedin.com/in/aaronlschacht/
BiomEdit: https://www.biomedit.com
Research paper: "How to improve R&D productivity: the pharmaceutical industry's grand challenge"
Link: https://www.nature.com/articles/nrd3078
Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.
